Cargando…

An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging

Developing activatable fluorescent probes with superlative fluorescence enhancement factor (F/F (0)) to improve the signal‐to‐noise (S/N) ratio is still an urgent issue. “AND” molecular logic gates are emerging as a useful tool for enhanced probes selectivity and accuracy. Here, an “AND” logic gate...

Descripción completa

Detalles Bibliográficos
Autores principales: Sang, Mangmang, Huang, Yibo, Wang, Lu, Chen, Lei, Nawsherwan, Li, Gang, Wang, Yan, Yu, Xiu, Dai, Cuilian, Zheng, Jinrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131802/
https://www.ncbi.nlm.nih.gov/pubmed/36808894
http://dx.doi.org/10.1002/advs.202207066
_version_ 1785031256570855424
author Sang, Mangmang
Huang, Yibo
Wang, Lu
Chen, Lei
Nawsherwan,
Li, Gang
Wang, Yan
Yu, Xiu
Dai, Cuilian
Zheng, Jinrong
author_facet Sang, Mangmang
Huang, Yibo
Wang, Lu
Chen, Lei
Nawsherwan,
Li, Gang
Wang, Yan
Yu, Xiu
Dai, Cuilian
Zheng, Jinrong
author_sort Sang, Mangmang
collection PubMed
description Developing activatable fluorescent probes with superlative fluorescence enhancement factor (F/F (0)) to improve the signal‐to‐noise (S/N) ratio is still an urgent issue. “AND” molecular logic gates are emerging as a useful tool for enhanced probes selectivity and accuracy. Here, an “AND” logic gate is developed as super‐enhancers for designing activatable probes with huge F/F (0) and S/N ratio. It utilizes lipid‐droplets (LDs) as controllable background input and sets the target analyte as variable input. The fluorescence is tremendously quenching due to double locking, thus an extreme F/F (0) ratio of target analyte is obtained. Importantly, this probe can transfer to LDs after a response occurs. The target analyte can be directly visualized through the spatial location without a control group. Accordingly, a peroxynitrite (ONOO(−)) activatable probe (CNP2‐B) is de novo designed. The F/F (0) of CNP2‐B achieves 2600 after reacting with ONOO(−). Furthermore, CNP2‐B can transfer from mitochondria to lipid droplets after being activated. The higher selectivity and S/N ratio of CNP2‐B are obtained than commercial probe 3'‐(p‐hydroxyphenyl) fluorescein (HPFin vitro and in vivo. Therefore, the atherosclerotic plaques at mouse models are delineated clearly after administration with in situ CNP2‐B probe gel. Such input controllable “AND” logic gate is envisioned to execute more imaging tasks.
format Online
Article
Text
id pubmed-10131802
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101318022023-04-27 An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging Sang, Mangmang Huang, Yibo Wang, Lu Chen, Lei Nawsherwan, Li, Gang Wang, Yan Yu, Xiu Dai, Cuilian Zheng, Jinrong Adv Sci (Weinh) Research Articles Developing activatable fluorescent probes with superlative fluorescence enhancement factor (F/F (0)) to improve the signal‐to‐noise (S/N) ratio is still an urgent issue. “AND” molecular logic gates are emerging as a useful tool for enhanced probes selectivity and accuracy. Here, an “AND” logic gate is developed as super‐enhancers for designing activatable probes with huge F/F (0) and S/N ratio. It utilizes lipid‐droplets (LDs) as controllable background input and sets the target analyte as variable input. The fluorescence is tremendously quenching due to double locking, thus an extreme F/F (0) ratio of target analyte is obtained. Importantly, this probe can transfer to LDs after a response occurs. The target analyte can be directly visualized through the spatial location without a control group. Accordingly, a peroxynitrite (ONOO(−)) activatable probe (CNP2‐B) is de novo designed. The F/F (0) of CNP2‐B achieves 2600 after reacting with ONOO(−). Furthermore, CNP2‐B can transfer from mitochondria to lipid droplets after being activated. The higher selectivity and S/N ratio of CNP2‐B are obtained than commercial probe 3'‐(p‐hydroxyphenyl) fluorescein (HPFin vitro and in vivo. Therefore, the atherosclerotic plaques at mouse models are delineated clearly after administration with in situ CNP2‐B probe gel. Such input controllable “AND” logic gate is envisioned to execute more imaging tasks. John Wiley and Sons Inc. 2023-02-19 /pmc/articles/PMC10131802/ /pubmed/36808894 http://dx.doi.org/10.1002/advs.202207066 Text en © 2023 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Sang, Mangmang
Huang, Yibo
Wang, Lu
Chen, Lei
Nawsherwan,
Li, Gang
Wang, Yan
Yu, Xiu
Dai, Cuilian
Zheng, Jinrong
An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging
title An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging
title_full An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging
title_fullStr An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging
title_full_unstemmed An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging
title_short An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging
title_sort “and” molecular logic gate as a super‐enhancers for de novo designing activatable probe and its application in atherosclerosis imaging
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131802/
https://www.ncbi.nlm.nih.gov/pubmed/36808894
http://dx.doi.org/10.1002/advs.202207066
work_keys_str_mv AT sangmangmang anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging
AT huangyibo anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging
AT wanglu anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging
AT chenlei anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging
AT nawsherwan anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging
AT ligang anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging
AT wangyan anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging
AT yuxiu anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging
AT daicuilian anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging
AT zhengjinrong anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging
AT sangmangmang andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging
AT huangyibo andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging
AT wanglu andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging
AT chenlei andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging
AT nawsherwan andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging
AT ligang andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging
AT wangyan andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging
AT yuxiu andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging
AT daicuilian andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging
AT zhengjinrong andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging